Get the Stockscreener App
114.11
1.77%
1.98
After Hours:
114.00
-0.11
-0.10%
Vaneck Pharmaceutical Etf stock is traded at $114.11, with a volume of 434.79K.
It is up +1.77% in the last 24 hours and up +3.24% over the past month.
See More
Previous Close:
$112.13
Open:
$114.14
24h Volume:
434.79K
Relative Volume:
1.18
Market Cap:
$1.07B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+4.52%
1M Performance:
+3.24%
6M Performance:
+10.42%
1Y Performance:
+23.86%
1-Day Range:
$114.04
$115.85
1-Week Range:
$108.66
$115.85
52-Week Range:
$90.60
$118.00
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
114.11 | 1.07B | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
709.43 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
775.16 | 889.50B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
771.79 | 815.11B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
378.42 | 696.97B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
728.00 | 486.89B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now? - Zacks Investment Research
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Motley Fool
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma - The Globe and Mail
Execution of Pharma Tariffs Brings These ETFs Into Focus - TradingView
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Zacks Investment Research
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance Singapore
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Globe and Mail
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.3600 - TradingView
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Motley Fool
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Globe and Mail
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Waverly Advisors LLC Has $4.23 Million Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Comparing Healthcare ETFs: Broad vs. Focused Exposure - Intellectia AI
Parker Hannifin Corp. stock outperforms competitors on strong trading day - MarketWatch
Parker-Hannifin (NYSE: PH) exec gives away 1,056 shares - Stock Titan
Q2 Earnings Highlights: Parker-Hannifin (NYSE:PH) Vs The Rest Of The Gas and Liquid Handling Stocks - Yahoo Finance
PH6508118 Bond Yield and Price — FINRA:PH6508118 - TradingView
Insider Transaction: Laura Thompson Sells $153K Worth Of Parker Hannifin Shares - Benzinga
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Motley Fool
Why is Parker-Hannifin (NYSE:PH) stock in focus today? - Kalkine Media
Tidal Investments LLC Has $19.99 Million Holdings in Parker-Hannifin Corporation $PH - MarketBeat
NewEdge Advisors LLC Boosts Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Globe and Mail
Director Laura Thompson Sells 160 Shares of Parker Hannifin Corp (PH) - GuruFocus
Parker-Hannifin Director Laura K. Thompson Sells 160 Shares at $958.95 Each - Kalkine Media
Parker Hannifin Corp. stock outperforms competitors despite losses on the day - MarketWatch
Parker-Hannifin prices $4.425B combined U.S. and Euro note offerings to refinance term loan - TradingView
Parker-Hannifin (NYSE: PH) Launches Euro Senior Notes Maturing in 2030, 2032, and 2036 to Finance FGC Acquisition Debt - Kalkine Media
Sequoia Financial Advisors LLC Increases Stake in Parker-Hannifin Corporation $PH - MarketBeat
National Pension Service Acquires 10,590 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Parker-Hannifin Corporation $PH Shares Sold by C WorldWide Group Holding A S - MarketBeat
Allworth Financial LP Acquires 1,598 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Baird Financial Group Inc. Increases Stock Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Parker-Hannifin Corporation $PH Shares Bought by Carmignac Gestion - MarketBeat
Parker-Hannifin Boosts Credit Facility, Commercial Paper Program to $5.0 Billion - Minichart
Form 424B2 Parker-Hannifin Corp - StreetInsider
Parker-Hannifin increases revolving credit and commercial paper to $5.0B, plans $2.0B delayed draw loan - TradingView
Anchor Capital Advisors LLC Sells 1,488 Shares of Parker-Hannifin Corporation $PH - MarketBeat
Director sells shares at $958.95 each at Parker-Hannifin (NYSE: PH) - Stock Titan
Parker-Hannifin (NYSE:PH): Can Its Order Pipeline Power the Stock? - Kalkine Media
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs - Zacks Investment Research
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs - tradingview.com
Hsbc Holdings PLC Has $229.28 Million Stock Position in Parker-Hannifin Corporation $PH - MarketBeat
Parker-Hannifin Corporation $PH Shares Bought by Groupe la Francaise - MarketBeat
Parker-Hannifin Corporation $PH Shares Acquired by California State Teachers Retirement System - MarketBeat
Amundi Raises Stock Holdings in Parker-Hannifin Corporation $PH - MarketBeat
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.44%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):